KLF9 and endometrium adenocarcinoma: A previous study has identified KLF9 as a direct PR-interacting protein [42,43] that functions as a transcriptional repressor at the node of the PR and ER genomic pathways to influence cell proliferation in the human endometrial adenocarcinoma cell line [32].